Event

OSCO 2021 ASCO Direct® Virtual Symposium

The Oklahoma Society of Clinical Oncology, Inc. would like to invite you to attend our fall meeting, ASCO Direct™, an officially licensed program of the American Society of Clinical Oncology®.  This virtual symposium is directed towards Hematologists and Oncologists, Nurses, Pharmacists, Physician Assistants and other health care professionals specializing in Oncology.  This meeting will break down the most clinically relevant abstracts from ASCO’s annual symposium, allowing attendees to engage with the latest strategies in oncology education.

  • Official ASCO Direct® is an officially licensed program of the American Society of Clinical Oncology®
  • This conference is jointly provided by Postgraduate Institute for Medicine and Oklahoma Society of Clinical Oncology, Inc.
  • This activity will be approved for AMA PRA Category 1 Credit(s) for physicians and education credits for other allied health professionals

Pharmaceutical Companies interested in Corporate Membership? Join here →

Companies interested in a virtual exhibit for Spring and/or Fall Conference? Purchase here →

Show Agenda
  • 7:30 AM
    Virtual Exhibitor Booths Open
  • 7:50 AM - 8:00 AM
    Welcome Remarks
    Jose Eugenio Najera, MD

    Jose Eugenio Najera, MD

    OSCO President

  • 8:00 AM - 8:15 AM
    Break with Virtual Exhibitors
  • 8:15 AM - 9:10 AM
    Topic: Update on Abstracts Relating to TNBC
    Kari Wisinski, MD

    Kari Wisinski, MD

    Associate Professor & Director of Breast Medical Oncology

    Division of Hematology/Oncology, University of Wisconsin Carbone Cancer Center

  • 9:10 AM - 9:25 AM
    Break with Virtual Exhibitors
  • 9:25 AM - 10:20 AM
    Topic: TBD
    Virginia G. Kaklamani, MD

    Virginia G. Kaklamani, MD

    Professor, Hematology/Oncology

    UT Health San Antonio - Mays Cancer Center

  • 10:20 AM - 10:35 AM
    Break with Virtual Exhibitors
  • 10:35 AM - 11:30 AM
    Topic: Residual Cancer Burden
    William Fraser Symmans, MB. ChB.

    William Fraser Symmans, MB. ChB.

    Director of Research Operations

    Department of Pathology - University of Texas MD Anderson

  • 11:30 AM - 11:45 AM
    Break with Virtual Exhibitors
  • 11:45 AM - 12:40 PM
    Topic: First Report on RxPONDER Trial
    Steven Vogl, MD

    Steven Vogl, MD

    Medical Oncology, Former Columnist for The ASCO Post, Bronx, NY

  • 12:40 PM
    Adjournment